← Back to Clinical Trials
Recruiting NCT07124676

NCT07124676 Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07124676
Status Recruiting
Phase
Sponsor University of Campania Luigi Vanvitelli
Condition Vaginal Laceration During Delivery
Study Type OBSERVATIONAL
Enrollment 482 participants
Start Date 2025-11-04
Primary Completion 2026-11-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 482 participants in total. It began in 2025-11-04 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn whether different classification systems for second-degree perineal tears can predict postpartum complications in women undergoing spontaneous vaginal childbirth. The main questions it aims to answer are: Does the Scandinavian classification better predict postpartum complications such as hemoglobin drop, perineal pain, occult muscle injury, and sexual dysfunction? Does the De Simone classification better correlate with these same postpartum outcomes? Researchers will compare the Scandinavian classification and the De Simone classification to see which system more accurately predicts clinically relevant postpartum complications. Participants will: Undergo standard clinical assessment after spontaneous vaginal delivery with a second-degree perineal tear Have their perineal tear classified using both the Scandinavian and De Simone systems Receive routine postpartum evaluation, including hemoglobin measurement, pain assessment (VAS), and perineal ultrasound Complete follow-up assessment of sexual function using the Female Sexual Function Index (FSFI)

Eligibility Criteria

Inclusion Criteria: * Female at birth * Age ≥ 18 years * Spontaneous vaginal delivery * Presence of a spontaneous second-degree perineal tear confirmed on -postpartum examination * Ability and willingness to provide informed consent Exclusion Criteria: * Obstetric or medical conditions preventing spontaneous vaginal delivery * Inability to understand study procedures or complete follow-up assessments

Contact & Investigator

Central Contact

Marco La Verde, MD, researcher

✉ marco.laverde@unicampania.it

📞 +393389412266

Frequently Asked Questions

Who can join the NCT07124676 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Vaginal Laceration During Delivery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07124676 currently recruiting?

Yes, NCT07124676 is actively recruiting participants. Contact the research team at marco.laverde@unicampania.it for enrollment information.

Where is the NCT07124676 trial being conducted?

This trial is being conducted at Naples, Italy.

Who is sponsoring the NCT07124676 clinical trial?

NCT07124676 is sponsored by University of Campania Luigi Vanvitelli. The trial plans to enroll 482 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology